Indoco Remedies surges on getting EU GMP certification for sterile manufacturing facility

16 Dec 2019 Evaluate

Indoco Remedies is currently trading at Rs. 154.35, up by 5.85 points or 3.94% from its previous closing of Rs. 148.50 on the BSE.

The scrip opened at Rs. 152.00 and has touched a high and low of Rs. 157.50 and Rs. 148.80 respectively. So far 2827 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 230.50 on 16-Jan-2019 and a 52 week low of Rs. 133.10 on 11-Oct-2019.

Last one week high and low of the scrip stood at Rs. 158.00 and Rs. 145.25 respectively. The current market cap of the company is Rs. 1380.41 crore.

The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 16.85% and 24.46% respectively.

Indoco Remedies has received EU GMP certification from the UK Health Regulator for its sterile manufacturing facility (Plant II) at Verna, Goa. This is an outcome from the last successful inspection conducted by UK MHRA from September 16, 2019 to September 20, 2019.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

330.00 -4.55 (-1.36%)
28-Mar-2024 14:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.40
Dr. Reddys Lab 6174.05
Cipla 1498.15
Zydus Lifesciences 1010.25
Lupin 1614.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.